Juri G Gelovani Selected Research

1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)

1/2020	Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
10/2019	Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
11/2016	Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.
11/2016	Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.
3/2016	AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.
3/2008	A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
1/2007	Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU.
4/2006	A hybrid vector for ligand-directed tumor targeting and molecular imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juri G Gelovani Research Topics

Disease

58	Neoplasms (Cancer) 01/2021 - 07/2004
7	Glioma (Gliomas) 01/2020 - 09/2004
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 04/2008
6	Carcinoma (Carcinomatosis) 01/2021 - 08/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2011
4	Neoplasm Metastasis (Metastasis) 11/2016 - 05/2006
3	Hypoxia (Hypoxemia) 01/2021 - 12/2009
3	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2004
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 04/2010
3	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 05/2008
3	Carcinogenesis 08/2012 - 12/2008
2	Alzheimer Disease (Alzheimer's Disease) 08/2021 - 05/2020
2	Hepatocellular Carcinoma (Hepatoma) 08/2012 - 06/2011
2	Brain Neoplasms (Brain Tumor) 01/2011 - 09/2004
2	Herpes Simplex 03/2009 - 03/2008
2	Sarcoma (Soft Tissue Sarcoma) 03/2008 - 07/2006
2	Melanoma (Melanoma, Malignant) 04/2006 - 10/2004
1	Brain Concussion (Cerebral Concussion) 01/2022
1	Cognitive Dysfunction 08/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2020
1	Pain (Aches) 01/2020
1	Microsatellite Instability 01/2018
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

10	LigandsIBA 01/2021 - 04/2006
8	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 01/2020 - 04/2006
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2005
8	Thymidine KinaseIBA 11/2016 - 11/2005
7	Peptides (Polypeptides)IBA 01/2017 - 10/2004
6	ErbB Receptors (EGF Receptor)IBA 01/2013 - 02/2008
6	Phosphotransferases (Kinase)IBA 01/2013 - 05/2005
4	Contrast MediaIBA 01/2021 - 11/2004
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 07/2006
4	Pharmaceutical PreparationsIBA 01/2017 - 03/2008
4	Ganciclovir (Cytovene)FDA LinkGeneric 11/2016 - 05/2006
4	Biomarkers (Surrogate Marker)IBA 11/2016 - 07/2006
4	ProdrugsIBA 11/2016 - 05/2006
3	Histone Deacetylases (Histone Deacetylase)IBA 08/2021 - 04/2013
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 09/2004
3	EnzymesIBA 01/2019 - 03/2009
3	Small Interfering RNA (siRNA)IBA 11/2016 - 04/2008
3	Endoplasmic Reticulum Chaperone BiPIBA 11/2016 - 10/2016
3	Coloring Agents (Dyes)IBA 10/2016 - 10/2004
3	Lactose FDA LinkGeneric 06/2013 - 11/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 11/2010
3	Gemcitabine FDA Link 08/2012 - 04/2008
3	Biological ProductsIBA 11/2011 - 10/2004
3	2'-fluoro-5-ethylarabinosyluracil (FEAU)IBA 01/2011 - 01/2007
2	6-(trifluoroacetamido)-1-hexanoicanilideIBA 01/2022 - 01/2019
2	CytokinesIBA 01/2021 - 11/2005
2	MC1568IBA 01/2020 - 01/2019
2	6- chloro- 2,3,4,9- tetrahydro- 1H- carbazole- 1- carboxamideIBA 01/2020 - 01/2019
2	Sirtuin 1IBA 01/2020 - 01/2019
2	IntegrinsIBA 01/2020 - 10/2011
2	alovudineIBA 01/2018 - 05/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 04/2013
2	Cell Surface ReceptorsIBA 11/2016 - 10/2016
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2016 - 02/2016
2	HydrogelsIBA 02/2016 - 04/2009
2	Histones (Histone)IBA 01/2015 - 04/2013
2	Gefitinib (Iressa)FDA Link 01/2013 - 01/2011
2	fialuridineIBA 08/2012 - 07/2006
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2012 - 11/2010
2	GoldIBA 10/2011 - 04/2010
2	Carrier Proteins (Binding Protein)IBA 06/2011 - 11/2009
2	CY5.5 cyanine dyeIBA 11/2009 - 10/2004
2	ThymidineIBA 08/2008 - 08/2006
2	src-Family KinasesIBA 05/2008 - 05/2005
2	Pentetic Acid (DTPA)FDA LinkGeneric 07/2007 - 04/2006
1	NimorazoleIBA 01/2021
1	Cyclic PeptidesIBA 01/2021
1	Protein Disulfide-IsomerasesIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021
1	Vorinostat FDA Link 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	PlatinumIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 05/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	fluorocholineIBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020
1	MutL Protein Homolog 1IBA 01/2018
1	Sirtuin 2IBA 01/2018
1	CarbohydratesIBA 01/2018
1	saccharide-binding proteinsIBA 01/2017
1	Annexin A2 (Annexin II)IBA 01/2017
1	Galectin 3 (LGALS3)IBA 01/2017

Therapy/Procedure

24	Therapeutics 01/2020 - 07/2004
5	Intravenous Injections 11/2009 - 11/2004
4	Precision Medicine 01/2021 - 10/2016
3	Drug Therapy (Chemotherapy) 08/2012 - 07/2007
2	Radiotherapy 01/2019 - 07/2007
2	Intravenous Administration 01/2018 - 04/2009
2	Oral Administration 08/2012 - 05/2012
2	Nanospheres 10/2011 - 04/2010
2	Gamma Cameras (Gamma Camera) 07/2006 - 05/2006
1	Aftercare (After-Treatment) 01/2020
1	Castration 11/2016